Literature DB >> 9262241

Malignant origin of the stromal component of Wilms' tumor.

K Pritchard-Jones.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9262241     DOI： 10.1093/jnci/89.15.1089

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

Review 1.  Wilms tumour: prognostic factors, staging, therapy and late effects.

Authors:  Sue C Kaste; Jeffrey S Dome; Paul S Babyn; Norbert M Graf; Paul Grundy; Jan Godzinski; Gill A Levitt; Helen Jenkinson
Journal:  Pediatr Radiol       Date:  2007-11-17

2.  Biomarker recommendation for PD-1/PD-L1 immunotherapy development in pediatric cancer based on digital image analysis of PD-L1 and immune cells.

Authors:  Manuel A Silva; Nicolas Triltsch; Simon Leis; Ivan Kanchev; Tze Heng Tan; Benjamine Van Peel; Marian Van Kerckhoven; Vanessa Deschoolmeester; Johannes Zimmermann
Journal:  J Pathol Clin Res       Date:  2020-01-10

3.  Stromal β-catenin activation impacts nephron progenitor differentiation in the developing kidney and may contribute to Wilms tumor.

Authors:  Keri A Drake; Christopher P Chaney; Amrita Das; Priti Roy; Callie S Kwartler; Dinesh Rakheja; Thomas J Carroll
Journal:  Development       Date:  2020-07-31       Impact factor: 6.868
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.